Thyrocare Technologies Ltd announces full repayment and release of NCD pledge
Thyrocare Technologies · Healthcare Services
Key highlights
- API Holdings Ltd fully redeemed ₹1,700 crore Non-Convertible Debentures secured by 60.92% equity pledge by Docon Technologies Pvt Ltd
- Catalyst Trusteeship Ltd, Debenture Trustee, issued No-Dues and Release Certificate on August 19, 2026
- Transaction Documents discharged and pledge over equity shares fully released, no impact on the company
Why it's rated notable: the amount is 183% of annual revenue (50% or more)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Disclosure under Regulation 30A of LODR
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- IIFL Finance Limited announces preferential issue of shares and amendments on Nov 10, 2026
- IIFL Finance to raise ₹6,414 crore in primary equity infusion led by Blackstone
- Bajaj Finserv subscribes to 5,74,25,740 Bajaj Finance warrants at ₹1,010 each
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.